Shear-dependent platelet aggregation by ChAdOx1 nCoV-19 vaccine: a novel biophysical mechanism for arterial thrombosis
Blood · 2025
DOI: 10.1182/blood.2024027675 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood, 2025. Verfasst von Yiyao Catherine Chen und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering, The University of Sydney, Darlington, NSW, Australia. Hauptthemen laut MEDLINE: Platelet Aggregation, Thrombosis, COVID-19 Vaccines. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Rare thrombotic events associated with ChAdOx1 nCoV-19 (ChAdOx1) vaccination have raised concerns; however, the underlying mechanisms remain elusive. Here, we report a novel biophysical mechanism by which ChAdOx1 directly interacts with platelets under arterial shear conditions, potentially contributing to postvaccination arterial thrombosis. Using microfluidic post assays, we demonstrate that ChAdOx1 induces shear-dependent platelet aggregation, distinct from conventional von Willebrand factor–mediated adhesion. This interaction is mediated by platelet integrin αIIbβ3 and requires biomechanical activation, explaining the absence of significant binding under static conditions. Molecular dynamics simulations and docking studies reveal preferential binding of ChAdOx1's penton arginine-glycine-aspartic acid (RGD) motif to the activated conformation of αIIbβ3. Inhibiting integrin αIIbβ3 completely abolishes ChAdOx1-induced platelet aggregation, whereas blocking glycoprotein (GP) Ib has minimal effect, confirming a mechanism that bypasses the conventional GPIb-dependent platelet adhesion pathway. Mutagenesis of the RGD motif to AAA eliminates platelet binding, verifying the specificity of this interaction. These findings provide a potential explanation for the association between ChAdOx1 vaccination and arterial thrombotic events, distinct from vaccine-induced immune thrombotic thrombocytopenia. Our results highlight the importance of considering biomechanical factors in vaccine-related thrombotic complications and suggest that shear-dependent integrin activation may be another determinant in the pathogenesis of these rare adverse events.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Biomedical Engineering, The University of Sydney, Darlington, NSW, Australia.
- Atherothrombosis and Vascular Biology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
- Charles Perkins Centre, The University of Sydney, Camperdown, NSW, Australia.
- Heart Research Institute, Newtown, NSW, Australia.
- The University of Sydney Nano Institute, The University of Sydney, Camperdown, NSW, Australia.
- Vaccines and Immune Therapies, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD.
ORCID-Profile: Yiyao Catherine Chen, Naveen Eugene Louis Richard Louis, Angela Huang, Allan Sun, Sarah C Gilbert, Huyen Tran, James D McFadyen, Lining Arnold Ju
Zitieren
APA
Chen, Y. C., Louis, N. E. L. R., Huang, A., Sun, A., Dupuy, A., Moldovan, L., Pelaia, T., Ren, J., Cohen, T. S., Gilbert, S. C., Tran, H., Peter, K., McFadyen, J. D., & Ju, L. A. (2025). Shear-dependent platelet aggregation by ChAdOx1 nCoV-19 vaccine: a novel biophysical mechanism for arterial thrombosis. Blood. https://doi.org/10.1182/blood.2024027675
Vancouver
Chen YC, Louis NELR, Huang A, Sun A, Dupuy A, Moldovan L, et al. Shear-dependent platelet aggregation by ChAdOx1 nCoV-19 vaccine: a novel biophysical mechanism for arterial thrombosis. Blood. 2025. doi:10.1182/blood.2024027675
BibTeX
@article{Chen2025,
author = {Chen, Yiyao Catherine and Louis, Naveen Eugene Louis Richard and Huang, Angela and Sun, Allan and Dupuy, Alexander and Moldovan, Laura and Pelaia, Tiana and Ren, Jianfang and Cohen, Taylor S and Gilbert, Sarah C and Tran, Huyen and Peter, Karlheinz and McFadyen, James D and Ju, Lining Arnold},
title = {Shear-dependent platelet aggregation by ChAdOx1 nCoV-19 vaccine: a novel biophysical mechanism for arterial thrombosis},
journal = {Blood},
year = {2025},
doi = {10.1182/blood.2024027675}
}
EUVIMED